Relationship between regional left ventricular dysfunction and cancer-therapy-related cardiac dysfunction.

Yoshihito SaijoKenya KusunoseYuichiro OkushiHirotsugu YamadaHiroaki TobaMasataka Sata

Published in: Heart (British Cardiac Society) (2020)

Basal-LS significantly decreased prior to development of CTRCD, and worse basal-LS was associated with development of CTRCD in patients receiving anthracycline chemotherapy.

Keyphrases

left ventricular
cancer therapy
oxidative stress
heart failure
drug delivery
acute myocardial infarction
hypertrophic cardiomyopathy
mitral valve
aortic stenosis
cardiac resynchronization therapy
left atrial
atrial fibrillation
catheter ablation